Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

New
New Allied Market Research

OTC Artificial Tears Market by Product Type (Solution, Ointment, Emulsion, Gel, Spray Solution, and Suspensions), Container Type (Plastic Single Dose Container, Plastic Multi-Dose Container, and Spray), Formulation (Preservative Based and Non-Preservative Based), Application (Dry Eye Syndrome, Allergies, Infections, UV and Blue Light Protection, Contact Lens Moisture Retention, and Others), and Distribution Channel (Hospital Pharmacies, Drug Stores, and Retail Pharmacies & Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021––2028

A11343
Pages: 376
May 2021 | 177 Views
 
Author(s) : Vishal Bhardwaj, Linu Dash , Onkar Sumant
Tables: 273
Charts: 61
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Otc Artificial Tears Market

Request Now !

OTC artificial tears market generated $4,379 million in 2020, and is projected to reach $6,399.43 million by 2028, growing at a CAGR of 4.94% from 2021 to 2028. Artificial tears also known as ocular lubricants are lubricating eye drops, which are formulated to provide relief from irritation, burning, discomfort, and dryness of the ocular surface. It maintains moisture at the outer surface of the eyes. Over-the-counter (OTC) artificial tears are the eye drops which are available without prescription. 

The COVID-19 outbreak is anticipated to have a moderate impact on the growth of the global OTC artificial tears market. The implementation of lockdown by governments has to lead to the disruption of the supply chain. However, the facility for non-essential medical products will improve the prospects of the market during the pandemic. The ease on over the counter (OTC) products such as artificial tears can further aid the speedy expansion of the market. The demand for teardrops in online pharmacies will subsequently propel the growth of the market

The growth of the global OTC artificial tears market is majorly driven by increase in geriatric population; rise in prevalence of eye diseases such as dry eye syndrome and allergic conjunctivitis; surge in demand for artificial tears products; and increase in investment in R&D activities by various healthcare companies. In addition, increase in number of eye surgeries, rise in awareness about management of dry eye syndrome, and initiatives taken by the government for the development & production of different novel OTC artificial tears propel the growth of the market. However, side effects associated with the OTC artificial tears such as blurred vision, redness around the eye, and skin rashes, are expected to restrict the OTC artificial tears market growth during the forecast period.

OTC-Artificial-Tears-Market,2021-2028

Get more information on this report : Request Sample Pages

Otc Artificial Tears Market Segmentation

The OTC artificial tears market is segmented into the product type, container type, formulation, application, distribution channel, and region. By product type, the market is divided into solution, ointment, emulsion, gel, spray solution, and suspensions. On the basis of container type, the market is fragmented into plastic single dose container, plastic multi-dose container, and spray. Further, plastic multi-dose container is bifurcated into preservative free system and preserved system.  On the basis of spray, the market is divided into preservative free system and preserved system. By formulation, the market is differentiated into preservative based and non-preservative based. By application, the market is divided into dry eye syndrome, allergies, infections, UV and Blue light protection, contact lens moisture retention and others. On the basis of distribution channel, the market is fragmented into hospital pharmacies, drug stores and retail pharmacies and online pharmacies. Region wise, the OTC artificial tears market is analyzed across North America, Europe, Asia-Pacific, Middle East, North Africa and Rest of World.

OTC Artificial Tears Market
By Product Type

Your browser does not support the canvas element.

Solution segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Segment review

Depending on the product type, the solution segment dominated the global OTC artificial tears market in 2020, and is anticipated to remain dominant during the forecast period, due to increase in demand for eye drops, surge in manufacturing of artificial tears for the treatment of dry eye diseases, and advancement in the R&D for novel ophthalmic product. However, the gel segment is expected to witness considerable growth during the forecast period due to increase in demand for eye gel and rise in number of key players for manufacturing combinational semisolid ophthalmic drug. 

On the basis of distribution channel, the Drug Store & Retail Pharmacies segment exhibited the highest growth rate in 2020, and is anticipated to lead in the near future due to rise in prevalence of dry eye syndrome diseases, increase in number of geriatric population, and development in technology in the healthcare sector. However, the online pharmacies segment is expected to witness considerable growth during the forecast period, due to gradual increase in the process of digitalization, sales of drugs at low cost, as well as increase in awareness about eye health support. 

OTC Artificial Tears Market
By Distribution Channel

Your browser does not support the canvas element.

Drug Stores & Retail Pharmacies held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

North America accounted for a major share in the OTC artificial tears market in 2020, and is expected to maintain its dominance during the forecast period, owing to rise in prevalence of dry eye diseases, presence of advanced healthcare infrastructure, as well as surge in the demand for OTC artificial tears. Furthermore, rise in awareness about the prevention and treatment of dry eye disease, and increase in demand for advanced healthcare facilities contribute toward the growth of the market. Moreover, upsurge in R&D activities in the healthcare sector to develop novel products and presence of major players operating in the region fuel the growth of the market. However, Asia-Pacific is expected to register the highest CAGR of 6.0% from 2021 to 2028, due to rise in prevalence of eye disease such as allergic conjunctivitis, dry eye syndrome, increase in number of eye surgeries for cataract and glaucoma, and rise in awareness about management of dry eye. 

The key players operating in the global market include AbbVie, Inc., Akorn, Inc., Alcon, Bausch & Lomb, Johnson & Johnson, Ocusoft, Santen Pharmaceutical Co. Ltd., Similasan Corporation, Sun Pharmaceutical Industries Limited and Ursapharm Arzneimittel GmbH.

OTC Artificial Tears Market
By Region

2028
North America 
Europe
Asia-pacific
Middle-east
North-africa And Rest Of World

North America was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the OTC artificial tears market, and the current trends and future estimations to elucidate the imminent investment pockets
  • It presents a quantitative analysis of the market from 2021 to 2028 to enable stakeholders to capitalize on the prevailing market opportunities
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the OTC artificial tears market

Key Market Segments

By Product

  • Solution
  • Ointment
  • Emulsion
  • Gel
  • Spray Solution
  • Suspensions

By Container Type

  • Plastic Single Dose Container
  • Plastic multi-dose containers
    • Preservative-Free System
    • Preserved System
  • Spray
    • Preservative-Free System
    • Preserved System

By Formulation

  • Preservative Based
  • Non-Preservative Based

By Application

  • Dry Eye Syndrome
  • Allergies
  • Infections
  • UV & Blue Light Protection
  • Contact Lens Moisture Retention
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Store & Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
    • U.S.
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Poland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Malaysia
    • Thailand
    • Philippines
    • Rest of Asia-Pacific
  • Middle East
    • UAE
    • Saudi Arabia
    • Palestine
    • Jordan
    • Bahrain
    • Qatar
    • Azerbaijan
    • Georgia
    • Iraq
    • Pakistan
    • Kuwait
    • Israel
    • Kazakhstan
    • Rest of Middle East
  • North Africa
    • Morocco
    • Algeria
    • Tunisia
    • Libya
    • Egypt
    • Rest of North Africa
  • Rest of World

Key Market Players 

  • AbbVie, Inc.
  • Akorn, Inc.
  • Alcon
  • Bausch and Lamb
  • Johnson and Johnson
  • OcuSoft
  • Santen Pharmaceutical Co. Ltd
  • Similasan Corporation 
  • Sun Pharmaceutical Industries Limited
  • Ursapharm Arzneimittel GmbH
 

CHAPTER 1:INTRODUCTION

1.1.REPORT DESCRIPTION
1.2.KEY MARKET SEGMENTS
1.3.KEY BENEFITS
1.4.RESEARCH METHODOLOGY

1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO PERSPECTIVE

CHAPTER 3:MARKET LANDSCAPE

3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.PORTER'S FIVE FORCES ANALYSIS

3.3.1.Bargaining power of suppliers
3.3.2.Threat of new entrants
3.3.3.Threat of substitutes
3.3.4.Competitive rivalry
3.3.5.Bargaining power among buyers

3.4.MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING 2019
3.5.MARKET DYNAMICS

3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities

3.6.IMPACT ANALYSIS OF COVID-19 ON MARKET

CHAPTER 4:OTC ARTIFICIAL TEARS MARKET BY PRODUCT TYPE

4.1.OVERVIEW
4.2.SOLUTION

4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast, by region 
4.2.3.Market share analysis, by country

4.3.OINTMENT

4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast, by region 
4.3.3.Market share analysis, by country

4.4.EMULSION

4.4.1.Key market trends, growth factors and opportunities
4.4.2.Market size and forecast, by region 
4.4.3.Market share analysis, by country

4.5.GEL

4.5.1.Key market trends, growth factors and opportunities
4.5.2.Market size and forecast, by region 
4.5.3.Market share analysis, by country

4.6.SPRAY SOLUTION

4.6.1.Key market trends, growth factors and opportunities
4.6.2.Market size and forecast, by region 
4.6.3.Market share analysis, by country

4.7.SUSPENSIONS

4.7.1.Key market trends, growth factors and opportunities
4.7.2.Market size and forecast, by region 
4.7.3.Market share analysis, by country

CHAPTER 5:OTC ARTIFICIAL TEARS MARKET BY CONTAINER TYPE

5.1.OVERVIEW
5.2.PLASTIC SINGLE DOSE CONTAINER

5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast, by region 
5.2.3.Market share analysis, by country

5.3.PLASTIC MULTI-DOSE CONTAINER

5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast, by region 
5.3.3.Market share analysis, by country
5.3.4.Preservative-free system

5.3.4.1.Market size and forecast

5.3.5.Preserved Systems

5.3.5.1.Market size and forecast

5.4.SPRAY

5.4.1.Key market trends, growth factors and opportunities
5.4.2.Market size and forecast, by region 
5.4.3.Market share analysis, by country
5.4.4.Preservative-free system

5.4.4.1.Market size and forecast

5.4.5.Preserved Systems

5.4.5.1.Market size and forecast

CHAPTER 6:OTC ARTIFICIAL TEARS MARKET BY FORMULATION

6.1.OVERVIEW
6.2.PRESERVATIVE BASED

6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by region 
6.2.3.Market share analysis, by country

6.3.NON-PRESERVATIVE BASED

6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by region 
6.3.3.Market share analysis, by country

CHAPTER 7:OTC ARTIFICIAL TEARS MARKET BY APPLICATION

7.1.OVERVIEW
7.2.DRY EYE SYNDROME

7.2.1.Key market trends, growth factors and opportunities
7.2.2.Market size and forecast, by region 
7.2.3.Market share analysis, by country

7.3.ALLERGIES

7.3.1.Key market trends, growth factors and opportunities
7.3.2.Market size and forecast, by region 
7.3.3.Market share analysis, by country

7.4.INFECTIONS

7.4.1.Key market trends, growth factors and opportunities
7.4.2.Market size and forecast, by region 
7.4.3.Market share analysis, by country

7.5.UV AND BLUE LIGHT PROTECTION

7.5.1.Key market trends, growth factors and opportunities
7.5.2.Market size and forecast, by region 
7.5.3.Market share analysis, by country

7.6.CONTACT LENS MOISTURE RETENTION

7.6.1.Key market trends, growth factors and opportunities
7.6.2.Market size and forecast, by region 
7.6.3.Market share analysis, by country

7.7.OTHERS

7.7.1.Key market trends, growth factors and opportunities
7.7.2.Market size and forecast, by region 
7.7.3.Market share analysis, by country

CHAPTER 8:OTC ARTIFICIAL TEARS MARKET BY DISTRIBUTION CHANNEL

8.1.OVERVIEW
8.2.HOSPITAL PHARMACIES

8.2.1.Key market trends, growth factors and opportunities
8.2.2.Market size and forecast, by region 
8.2.3.Market share analysis, by country

8.3.DRUG STORE AND RETAIL PHARMACIES

8.3.1.Key market trends, growth factors and opportunities
8.3.2.Market size and forecast, by region 
8.3.3.Market share analysis, by country

8.4.ONLINE PHARMACIES

8.4.1.Key market trends, growth factors and opportunities
8.4.2.Market size and forecast, by region 
8.4.3.Market share analysis, by country

CHAPTER 9:OTC ARTIFICIAL TEARS MARKET BY REGION

9.1.OVERVIEW
9.2.NORTH AMERICA

9.2.1.Key market trends and opportunities
9.2.2.Market size and forecast, by product type
9.2.3.Market size and forecast, by container type
9.2.4.Market size and forecast, by formulation
9.2.5.Market size and forecast, by application
9.2.6.Market size and forecast, by distribution channel
9.2.7.Market size and forecast, by Country
9.2.8.U.S.

9.2.8.1.Market size and forecast, by product type
9.2.8.2.Market size and forecast, by container type
9.2.8.3.Market size and forecast, by formulation
9.2.8.4.Market size and forecast, by application
9.2.8.5.Market size and forecast, by distribution channel

9.2.9.Rest of North America

9.2.9.1.Market size and forecast, by product type
9.2.9.2.Market size and forecast, by container type
9.2.9.3.Market size and forecast, by formulation
9.2.9.4.Market size and forecast, by application
9.2.9.5.Market size and forecast, by distribution channel

9.3.EUROPE

9.3.1.Key market trends and opportunities
9.3.2.Market size and forecast, by product type
9.3.3.Market size and forecast, by container type
9.3.4.Market size and forecast, by formulation
9.3.5.Market size and forecast, by application
9.3.6.Market size and forecast, by distribution channel
9.3.7.Market size and forecast, by Country
9.3.8.UK

9.3.8.1.Market size and forecast, by product type
9.3.8.2.Market size and forecast, by container type
9.3.8.3.Market size and forecast, by formulation
9.3.8.4.Market size and forecast, by application
9.3.8.5.Market size and forecast, by distribution channel

9.3.9.Germany

9.3.9.1.Market size and forecast, by product type
9.3.9.2.Market size and forecast, by container type
9.3.9.3.Market size and forecast, by formulation
9.3.9.4.Market size and forecast, by application
9.3.9.5.Market size and forecast, by distribution channel

9.3.10.France

9.3.10.1.Market size and forecast, by product type
9.3.10.2.Market size and forecast, by container type
9.3.10.3.Market size and forecast, by formulation
9.3.10.4.Market size and forecast, by application
9.3.10.5.Market size and forecast, by distribution channel

9.3.11.Italy

9.3.11.1.Market size and forecast, by product type
9.3.11.2.Market size and forecast, by container type
9.3.11.3.Market size and forecast, by formulation
9.3.11.4.Market size and forecast, by application
9.3.11.5.Market size and forecast, by distribution channel

9.3.12.Spain

9.3.12.1.Market size and forecast, by product type
9.3.12.2.Market size and forecast, by container type
9.3.12.3.Market size and forecast, by formulation
9.3.12.4.Market size and forecast, by application
9.3.12.5.Market size and forecast, by distribution channel

9.3.13.Poland

9.3.13.1.Market size and forecast, by product type
9.3.13.2.Market size and forecast, by container type
9.3.13.3.Market size and forecast, by formulation
9.3.13.4.Market size and forecast, by application
9.3.13.5.Market size and forecast, by distribution channel

9.3.14.Rest of Europe

9.3.14.1.Market size and forecast, by product type
9.3.14.2.Market size and forecast, by container type
9.3.14.3.Market size and forecast, by formulation
9.3.14.4.Market size and forecast, by application
9.3.14.5.Market size and forecast, by distribution channel

9.4.ASIA-PACIFIC

9.4.1.Key market trends and opportunities
9.4.2.Market size and forecast, by product type
9.4.3.Market size and forecast, by container type
9.4.4.Market size and forecast, by formulation
9.4.5.Market size and forecast, by application
9.4.6.Market size and forecast, by distribution channel
9.4.7.Market size and forecast, by Country
9.4.8.Japan

9.4.8.1.Market size and forecast, by product type
9.4.8.2.Market size and forecast, by container type
9.4.8.3.Market size and forecast, by formulation
9.4.8.4.Market size and forecast, by application
9.4.8.5.Market size and forecast, by distribution channel

9.4.9.China

9.4.9.1.Market size and forecast, by product type
9.4.9.2.Market size and forecast, by container type
9.4.9.3.Market size and forecast, by formulation
9.4.9.4.Market size and forecast, by application
9.4.9.5.Market size and forecast, by distribution channel

9.4.10.India

9.4.10.1.Market size and forecast, by product type
9.4.10.2.Market size and forecast, by container type
9.4.10.3.Market size and forecast, by formulation
9.4.10.4.Market size and forecast, by application
9.4.10.5.Market size and forecast, by distribution channel

9.4.11.Malaysia

9.4.11.1.Market size and forecast, by product type
9.4.11.2.Market size and forecast, by container type
9.4.11.3.Market size and forecast, by formulation
9.4.11.4.Market size and forecast, by application
9.4.11.5.Market size and forecast, by distribution channel

9.4.12.Vietnam

9.4.12.1.Market size and forecast, by product type
9.4.12.2.Market size and forecast, by container type
9.4.12.3.Market size and forecast, by formulation
9.4.12.4.Market size and forecast, by application
9.4.12.5.Market size and forecast, by distribution channel

9.4.13.Thailand

9.4.13.1.Market size and forecast, by product type
9.4.13.2.Market size and forecast, by container type
9.4.13.3.Market size and forecast, by formulation
9.4.13.4.Market size and forecast, by application
9.4.13.5.Market size and forecast, by distribution channel

9.4.14.Philippines

9.4.14.1.Market size and forecast, by product type
9.4.14.2.Market size and forecast, by container type
9.4.14.3.Market size and forecast, by formulation
9.4.14.4.Market size and forecast, by application
9.4.14.5.Market size and forecast, by distribution channel

9.4.15.Rest of Asia-Pacific

9.4.15.1.Market size and forecast, by product type
9.4.15.2.Market size and forecast, by container type
9.4.15.3.Market size and forecast, by formulation
9.4.15.4.Market size and forecast, by application
9.4.15.5.Market size and forecast, by distribution channel

9.5.MIDDLE EAST

9.5.1.Key market trends and opportunities
9.5.2.Market size and forecast, by product type
9.5.3.Market size and forecast, by container type
9.5.4.Market size and forecast, by formulation
9.5.5.Market size and forecast, by application
9.5.6.Market size and forecast, by distribution channel
9.5.7.Market size and forecast, by Country
9.5.8.UAE

9.5.8.1.Market size and forecast, by product type
9.5.8.2.Market size and forecast, by container type
9.5.8.3.Market size and forecast, by formulation
9.5.8.4.Market size and forecast, by application
9.5.8.5.Market size and forecast, by distribution channel

9.5.9.Saudi Arabia

9.5.9.1.Market size and forecast, by product type
9.5.9.2.Market size and forecast, by container type
9.5.9.3.Market size and forecast, by formulation
9.5.9.4.Market size and forecast, by application
9.5.9.5.Market size and forecast, by distribution channel

9.5.10.Palestine

9.5.10.1.Market size and forecast, by product type
9.5.10.2.Market size and forecast, by container type
9.5.10.3.Market size and forecast, by formulation
9.5.10.4.Market size and forecast, by application
9.5.10.5.Market size and forecast, by distribution channel

9.5.11.Jordan

9.5.11.1.Market size and forecast, by product type
9.5.11.2.Market size and forecast, by container type
9.5.11.3.Market size and forecast, by formulation
9.5.11.4.Market size and forecast, by application
9.5.11.5.Market size and forecast, by distribution channel

9.5.12.Bahrein

9.5.12.1.Market size and forecast, by product type
9.5.12.2.Market size and forecast, by container type
9.5.12.3.Market size and forecast, by formulation
9.5.12.4.Market size and forecast, by application
9.5.12.5.Market size and forecast, by distribution channel

9.5.13.Qatar

9.5.13.1.Market size and forecast, by product type
9.5.13.2.Market size and forecast, by container type
9.5.13.3.Market size and forecast, by formulation
9.5.13.4.Market size and forecast, by application

9.5.13.5.Market size and forecast, by distribution channel

9.5.14.Azerbaijan

9.5.14.1.Market size and forecast, by product type
9.5.14.2.Market size and forecast, by container type
9.5.14.3.Market size and forecast, by formulation
9.5.14.4.Market size and forecast, by application
9.5.14.5.Market size and forecast, by distribution channel

9.5.15.Georgia

9.5.15.1.Market size and forecast, by product type
9.5.15.2.Market size and forecast, by container type
9.5.15.3.Market size and forecast, by formulation
9.5.15.4.Market size and forecast, by application
9.5.15.5.Market size and forecast, by distribution channel

9.5.16.Iraq

9.5.16.1.Market size and forecast, by product type
9.5.16.2.Market size and forecast, by container type
9.5.16.3.Market size and forecast, by formulation
9.5.16.4.Market size and forecast, by application
9.5.16.5.Market size and forecast, by distribution channel

9.5.17.Pakistan

9.5.17.1.Market size and forecast, by product type
9.5.17.2.Market size and forecast, by container type
9.5.17.3.Market size and forecast, by formulation
9.5.17.4.Market size and forecast, by application
9.5.17.5.Market size and forecast, by distribution channel

9.5.18.Kuwait

9.5.18.1.Market size and forecast, by product type
9.5.18.2.Market size and forecast, by container type
9.5.18.3.Market size and forecast, by formulation
9.5.18.4.Market size and forecast, by application
9.5.18.5.Market size and forecast, by distribution channel

9.5.19.Israel

9.5.19.1.Market size and forecast, by product type
9.5.19.2.Market size and forecast, by container type
9.5.19.3.Market size and forecast, by formulation
9.5.19.4.Market size and forecast, by application
9.5.19.5.Market size and forecast, by distribution channel

9.5.20.Kazakhstan

9.5.20.1.Market size and forecast, by product type
9.5.20.2.Market size and forecast, by container type
9.5.20.3.Market size and forecast, by formulation
9.5.20.4.Market size and forecast, by application
9.5.20.5.Market size and forecast, by distribution channel

9.5.21.Rest of Middle East

9.5.21.1.Market size and forecast, by product type
9.5.21.2.Market size and forecast, by container type
9.5.21.3.Market size and forecast, by formulation
9.5.21.4.Market size and forecast, by application
9.5.21.5.Market size and forecast, by distribution channel

9.6.NORTH AFRICA

9.6.1.Key market trends and opportunities
9.6.2.Market size and forecast, by product type
9.6.3.Market size and forecast, by container type
9.6.4.Market size and forecast, by formulation
9.6.5.Market size and forecast, by application
9.6.6.Market size and forecast, by distribution channel
9.6.7.Market size and forecast, by Country
9.6.8.Morocco

9.6.8.1.Market size and forecast, by product type
9.6.8.2.Market size and forecast, by container type
9.6.8.3.Market size and forecast, by formulation
9.6.8.4.Market size and forecast, by application
9.6.8.5.Market size and forecast, by distribution channel

9.6.9.Algeria

9.6.9.1.Market size and forecast, by product type
9.6.9.2.Market size and forecast, by container type
9.6.9.3.Market size and forecast, by formulation
9.6.9.4.Market size and forecast, by application
9.6.9.5.Market size and forecast, by distribution channel

9.6.10.Tunisia 

9.6.10.1.Market size and forecast, by product type
9.6.10.2.Market size and forecast, by container type
9.6.10.3.Market size and forecast, by formulation
9.6.10.4.Market size and forecast, by application
9.6.10.5.Market size and forecast, by distribution channel

9.6.11.Libia

9.6.11.1.Market size and forecast, by product type
9.6.11.2.Market size and forecast, by container type
9.6.11.3.Market size and forecast, by formulation
9.6.11.4.Market size and forecast, by application
9.6.11.5.Market size and forecast, by distribution channel

9.6.12.Egypt

9.6.12.1.Market size and forecast, by product type
9.6.12.2.Market size and forecast, by container type
9.6.12.3.Market size and forecast, by formulation
9.6.12.4.Market size and forecast, by application
9.6.12.5.Market size and forecast, by distribution channel

9.6.13.Rest of North Africa

9.6.13.1.Market size and forecast, by product type
9.6.13.2.Market size and forecast, by container type
9.6.13.3.Market size and forecast, by formulation
9.6.13.4.Market size and forecast, by application
9.6.13.5.Market size and forecast, by distribution channel

CHAPTER 10:COMPANY PROFILES

10.1.SANTEN PHARMACEUTICAL

10.1.1.Company overview
10.1.2.Key Executives
10.1.3.Company snapshot
10.1.4.Operating business segments
10.1.5.Product portfolio
10.1.6.Business performance
10.1.7.Key strategic moves and developments

10.2.BAUSCH & LOMB

10.2.1.Company overview
10.2.2.Key Executives
10.2.3.Company snapshot
10.2.4.Operating business segments
10.2.5.Product portfolio
10.2.6.Business performance
10.2.7.Key strategic moves and developments

10.3.ALLERGAN

10.3.1.Company overview
10.3.2.Key Executives
10.3.3.Company snapshot
10.3.4.Operating business segments
10.3.5.Product portfolio
10.3.6.Business performance
10.3.7.Key strategic moves and developments

10.4.ABBOTT LABORATORIES

10.4.1.Company overview
10.4.2.Key Executives
10.4.3.Company snapshot
10.4.4.Operating business segments
10.4.5.Product portfolio
10.4.6.Business performance
10.4.7.Key strategic moves and developments

10.5.JOHNSON & JOHNSON

10.5.1.Company overview
10.5.2.Key Executives
10.5.3.Company snapshot
10.5.4.Operating business segments
10.5.5.Product portfolio
10.5.6.Business performance
10.5.7.Key strategic moves and developments

10.6.LUMECARE

10.6.1.Company overview
10.6.2.Key Executives
10.6.3.Company snapshot
10.6.4.Operating business segments
10.6.5.Product portfolio
10.6.6.Business performance
10.6.7.Key strategic moves and developments

10.7.SIMILASAN CORPORATION

10.7.1.Company overview
10.7.2.Key Executives
10.7.3.Company snapshot
10.7.4.Operating business segments
10.7.5.Product portfolio
10.7.6.Business performance
10.7.7.Key strategic moves and developments

10.8.URSAPHARM

10.8.1.Company overview
10.8.2.Key Executives
10.8.3.Company snapshot
10.8.4.Operating business segments
10.8.5.Product portfolio
10.8.6.Business performance
10.8.7.Key strategic moves and developments

10.9.NOVARTIS AG (ALCON)

10.9.1.Company overview
10.9.2.Key Executives
10.9.3.Company snapshot
10.9.4.Operating business segments
10.9.5.Product portfolio
10.9.6.Business performance
10.9.7.Key strategic moves and developments

10.10.OCUSOFT

10.10.1.Company overview
10.10.2.Key Executives
10.10.3.Company snapshot
10.10.4.Operating business segments
10.10.5.Product portfolio
10.10.6.Business performance
10.10.7.Key strategic moves and developments

Note:
o*Details on financial performance and strategic moves and developments may not be captured for unlisted companies.
o*List of companies profiled in this TOC is tentative and may change after detailed analysis.
o*Market size and forecast will be provided from 2019-2027, and forecast period would be 2020-2027.

LIST OF TABLES

TABLE 1.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 2.OTC ARTIFICIAL TEARS MARKET FOR SOLUTION, BY REGION,  2019-2027 ($MILLION)
TABLE 3.OTC ARTIFICIAL TEARS MARKET FOR OINTMENT, BY REGION,  2019-2027 ($MILLION)
TABLE 4.OTC ARTIFICIAL TEARS MARKET FOR EMULSION, BY REGION,  2019-2027 ($MILLION)
TABLE 5.OTC ARTIFICIAL TEARS MARKET FOR GEL, BY REGION,  2019-2027 ($MILLION)
TABLE 6.OTC ARTIFICIAL TEARS MARKET FOR SPRAY SOLUTION, BY REGION,  2019-2027 ($MILLION)
TABLE 7.OTC ARTIFICIAL TEARS MARKET FOR SUSPENSIONS, BY REGION,  2019-2027 ($MILLION)
TABLE 8.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 9.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC SINGLE DOSE CONTAINER, BY REGION,  2019-2027 ($MILLION)
TABLE 10.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC MULTI-DOSE CONTAINER, BY REGION,  2019-2027 ($MILLION)
TABLE 11.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE-FREE SYSTEM, BY REGION,  2019-2027 ($MILLION)
TABLE 12.OTC ARTIFICIAL TEARS MARKET FOR  PRESERVED SYSTEMS, BY REGION,  2019-2027 ($MILLION)
TABLE 13.OTC ARTIFICIAL TEARS MARKET FOR SPRAY, BY REGION,  2019-2027 ($MILLION)
TABLE 14.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE-FREE SYSTEM, BY REGION,  2019-2027 ($MILLION)
TABLE 15.OTC ARTIFICIAL TEARS MARKET FOR  PRESERVED SYSTEMS, BY REGION,  2019-2027 ($MILLION)
TABLE 16.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY FORMULATION 2019-2027 ($MILLION)
TABLE 17.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE BASED, BY REGION,  2019-2027 ($MILLION)
TABLE 18.OTC ARTIFICIAL TEARS MARKET FOR NON-PRESERVATIVE BASED, BY REGION,  2019-2027 ($MILLION)
TABLE 19.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY APPLICATION 2019-2027 ($MILLION)
TABLE 20.OTC ARTIFICIAL TEARS MARKET FOR DRY EYE SYNDROME, BY REGION,  2019-2027 ($MILLION)
TABLE 21.OTC ARTIFICIAL TEARS MARKET FOR ALLERGIES, BY REGION,  2019-2027 ($MILLION)
TABLE 22.OTC ARTIFICIAL TEARS MARKET FOR INFECTIONS, BY REGION,  2019-2027 ($MILLION)
TABLE 23.OTC ARTIFICIAL TEARS MARKET FOR UV AND BLUE LIGHT PROTECTION, BY REGION,  2019-2027 ($MILLION)
TABLE 24.OTC ARTIFICIAL TEARS MARKET FOR CONTACT LENS MOISTURE RETENTION, BY REGION,  2019-2027 ($MILLION)
TABLE 25.OTC ARTIFICIAL TEARS MARKET FOR OTHERS, BY REGION,  2019-2027 ($MILLION)
TABLE 26.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 27.OTC ARTIFICIAL TEARS MARKET FOR HOSPITAL PHARMACIES, BY REGION,  2019-2027 ($MILLION)
TABLE 28.OTC ARTIFICIAL TEARS MARKET FOR DRUG STORE AND RETAIL PHARMACIES, BY REGION,  2019-2027 ($MILLION)
TABLE 29.OTC ARTIFICIAL TEARS MARKET FOR ONLINE PHARMACIES, BY REGION,  2019-2027 ($MILLION)
TABLE 30.OTC ARTIFICIAL TEARS MARKET FOR , BY REGION, , 2019-2027 ($MILLION)
TABLE 31.NORTH AMERICA OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 32.NORTH AMERICA OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 33.NORTH AMERICA OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 34.NORTH AMERICA OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 35.NORTH AMERICA OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 36.NORTH AMERICA OTC ARTIFICIAL TEARS, BY REGION,  2019-2027 ($MILLION)
TABLE 37.EUROPE OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 38.EUROPE OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 39.EUROPE OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 40.EUROPE OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 41.EUROPE OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 42.EUROPE OTC ARTIFICIAL TEARS, BY REGION,  2019-2027 ($MILLION)
TABLE 43.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 44.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 45.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 46.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 47.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 48.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY REGION,  2019-2027 ($MILLION)
TABLE 49.MIDDLE EAST OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 50.MIDDLE EAST OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 51.MIDDLE EAST OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 52.MIDDLE EAST OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 53.MIDDLE EAST OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 54.MIDDLE EAST OTC ARTIFICIAL TEARS, BY REGION,  2019-2027 ($MILLION)
TABLE 55.NORTH AFRICA OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 56.NORTH AFRICA OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 57.NORTH AFRICA OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 58.NORTH AFRICA OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 59.NORTH AFRICA OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 60.NORTH AFRICA OTC ARTIFICIAL TEARS, BY REGION,  2019-2027 ($MILLION)
TABLE 61.SANTEN PHARMACEUTICAL: COMPANY SNAPSHOT
TABLE 62.SANTEN PHARMACEUTICAL: OPERATING SEGMENTS
TABLE 63.BAUSCH & LOMB: COMPANY SNAPSHOT
TABLE 64.BAUSCH & LOMB: OPERATING SEGMENTS
TABLE 65.ALLERGAN: COMPANY SNAPSHOT
TABLE 66.ALLERGAN: OPERATING SEGMENTS
TABLE 67.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 68.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 69.JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 70.JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 71.LUMECARE: COMPANY SNAPSHOT
TABLE 72.LUMECARE: OPERATING SEGMENTS
TABLE 73.SIMILASAN CORPORATION: COMPANY SNAPSHOT
TABLE 74.SIMILASAN CORPORATION: OPERATING SEGMENTS
TABLE 75.URSAPHARM: COMPANY SNAPSHOT
TABLE 76.URSAPHARM: OPERATING SEGMENTS
TABLE 77.NOVARTIS AG (ALCON): COMPANY SNAPSHOT
TABLE 78.NOVARTIS AG (ALCON): OPERATING SEGMENTS
TABLE 79.OCUSOFT: COMPANY SNAPSHOT
TABLE 80.OCUSOFT: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1.GLOBAL OTC ARTIFICIAL TEARS MARKET SEGMENTATION
FIGURE 2.TOP INVESTMENT POCKET
FIGURE 3.TOP WINNING STRATEGIES (%)
FIGURE 4.OTC ARTIFICIAL TEARS MARKET FOR SOLUTION, 2019-2027 ($MILLION)
FIGURE 5.OTC ARTIFICIAL TEARS MARKET FOR OINTMENT, 2019-2027 ($MILLION)
FIGURE 6.OTC ARTIFICIAL TEARS MARKET FOR EMULSION, 2019-2027 ($MILLION)
FIGURE 7.OTC ARTIFICIAL TEARS MARKET FOR GEL, 2019-2027 ($MILLION)
FIGURE 8.OTC ARTIFICIAL TEARS MARKET FOR SPRAY SOLUTION, 2019-2027 ($MILLION)
FIGURE 9.OTC ARTIFICIAL TEARS MARKET FOR SUSPENSIONS, 2019-2027 ($MILLION)
FIGURE 10.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC SINGLE DOSE CONTAINER, 2019-2027 ($MILLION)
FIGURE 11.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC MULTI-DOSE CONTAINER, 2019-2027 ($MILLION)
FIGURE 12.OTC ARTIFICIAL TEARS MARKET FOR SPRAY, 2019-2027 ($MILLION)
FIGURE 13.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE BASED, 2019-2027 ($MILLION)
FIGURE 14.OTC ARTIFICIAL TEARS MARKET FOR NON-PRESERVATIVE BASED, 2019-2027 ($MILLION)
FIGURE 15.OTC ARTIFICIAL TEARS MARKET FOR DRY EYE SYNDROME, 2019-2027 ($MILLION)
FIGURE 16.OTC ARTIFICIAL TEARS MARKET FOR ALLERGIES, 2019-2027 ($MILLION)
FIGURE 17.OTC ARTIFICIAL TEARS MARKET FOR INFECTIONS, 2019-2027 ($MILLION)
FIGURE 18.OTC ARTIFICIAL TEARS MARKET FOR UV AND BLUE LIGHT PROTECTION, 2019-2027 ($MILLION)
FIGURE 19.OTC ARTIFICIAL TEARS MARKET FOR CONTACT LENS MOISTURE RETENTION, 2019-2027 ($MILLION)
FIGURE 20.OTC ARTIFICIAL TEARS MARKET FOR OTHERS, 2019-2027 ($MILLION)
FIGURE 21.OTC ARTIFICIAL TEARS MARKET FOR HOSPITAL PHARMACIES, 2019-2027 ($MILLION)
FIGURE 22.OTC ARTIFICIAL TEARS MARKET FOR DRUG STORE AND RETAIL PHARMACIES, 2019-2027 ($MILLION)
FIGURE 23.OTC ARTIFICIAL TEARS MARKET FOR ONLINE PHARMACIES, 2019-2027 ($MILLION)
FIGURE 24.GLOBAL OTC ARTIFICIAL TEARS, BY REGION,  2019 (%)
FIGURE 25.U.S. OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 26.REST OF NORTH AMERICA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 27.UK OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 28.GERMANY OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 29.FRANCE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 30.ITALY OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 31.SPAIN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 32.POLAND OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 33.REST OF EUROPE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 34.JAPAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 35.CHINA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 36.INDIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 37.MALAYSIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 38.VIETNAM OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 39.THAILAND OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 40.PHILIPPINES OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 41.REST OF ASIA-PACIFIC OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 42.UAE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 43.SAUDI ARABIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 44.PALESTINE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 45.JORDAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 46.BAHREIN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 47.QATAR OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 48.AZERBAIJAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 49.GEORGIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 50.IRAQ OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 51.PAKISTAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 52.KUWAIT OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 53.ISRAEL OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 54.KAZAKHSTAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 55.REST OF MIDDLE EAST OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 56.MOROCCO OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 57.ALGERIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 58.TUNISIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 59.LIBIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 60.EGYPT OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 61.REST OF NORTH AFRICA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)

 
 

According to analyst perspective, the growth of the OTC artificial tears market is attributed to factors such as technological advancements in R&D for ophthalmology; rise in prevalence of dry eye diseases; increase in geriatric population; and surge in awareness among consumers regarding eye health. OTC artificial tears experience an increase in demand due to rise in eye surgeries such as cataract surgeries and glaucoma surgeries. The OTC artificial tears market has gained high traction in the healthcare industry over years, as these drugs are intended for the treatment of dry eye syndrome and post-operative management.

Further, North America is expected to witness highest growth in terms of revenue, due to the prevalence of dry eye syndrome, increase in awareness about prevention, adoption of sophisticated products, advancement in healthcare sector, and rise in the geriatric population. 

In addition, the risk of contamination and adverse reactions associated with OTC artificial tears such as blurred vision, eye pain, skin rash, and redness around the eye are anticipated to restrain the market growth during the forecast period.

 
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of OTC artificial tears Market is $4379 million in 2020

A. The forecast period in the report is 2021 to 2028

A. The market value of OTC artificial tears market in 2028 is $6399.43 Million

A. The base year is 2020 in OTC artificial tears Market .

A. Yes, OTC artificial tears companies are profiled in the report

A. The top companies that are covered in OTC artificial tears Market are AbbVie, Inc., Akorn, Inc., Alcon, Bausch & Lomb, Johnson & Johnson, Ocusoft, Santen Pharmaceutical Co. Ltd, Similasan Corporation, Sun Pharmaceutical Industries Limited and Ursapharm Arzneimittel GmbH.

A. No, there is no value chain analysis provided in the OTC artificial tears Market report

A. The key trends in the OTC artificial tears Market are increase in prevelence of dry eye syndrome, rise in the number of eye surgeries and advancement in research and development in optometry.

Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
OTC Artificial Tears Market

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers